OTCM
ONVVF
Market cap67mUSD
Nov 03, Last price
0.16USD
Name
Oneview Healthcare PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Oneview Healthcare PLC, headquartered in Dublin, Ireland since its establishment in 2008, specializes in furnishing bespoke software and expert consulting services. These offerings are tailored for the global healthcare industry, with a presence spanning Ireland, the United States, Australia, Asia, and the Middle East. The company's core offerings revolve around its Care Experience Platform (CXP), which includes several distinct solutions: CXP Cloud Start: Designed to enable clients to seamlessly deploy essential digital engagement functionalities across their entire organizational footprint. CXP Cloud Enterprise: This solution empowers patients and their relatives to communicate virtually with healthcare providers, while also providing access to vital educational resources and health-related information. CXP Enterprise On-Prem: A robust on-premise offering engineered to address diverse institutional requirements, suitable for a wide range of facilities, from new construction projects to existing hospitals utilizing legacy infrastructure. Furthermore, Oneview Healthcare also provides specialized tools aimed at enhancing patient and family empowerment, optimizing the overall patient experience, facilitating remote virtual care delivery, and offering solutions like digital room signage and interactive patient communication boards.
Key people
James Fitter
Chief Executive Officer, Executive Director · since 2009
Darragh Lyons
Chief Financial Officer, Director · since 2024
Niall ONeill
Chief Operating Officer · since 2014
Toni Pettit
Company Secretary · since 2024
Michael Dowling
Non-Executive Director · since 2025
Joseph Rooney
Non-Executive Director · since 2024
Barbara Nelson
Non-Executive Independent Chairman of the Board · since 2024
Nashina Asaria
Non-Executive Independent Director · since 2021
Mark Cullen
Non-Executive Independent Director · since 2023
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||